Healthcare provider profile · identity verified

Anthony Ohotto, M.D.

Family Medicine · PORTLAND, OR · NPI 1649231226

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	536	58
Memantine Hcl	Memantine Hcl	476	49
Lisinopril	Lisinopril	377	38
Omeprazole	Omeprazole	363	44
Oxycodone Hcl	Oxycodone Hcl	363	60
Donepezil Hcl	Donepezil Hcl	245	26
Levothyroxine Sodium	Levothyroxine Sodium	237	26
Furosemide	Furosemide	235	29
Metformin Hcl Er	Metformin Hcl	235	25
Alendronate Sodium	Alendronate Sodium	232	26
Gabapentin	Gabapentin	216	21
Trazodone Hcl	Trazodone Hcl	216	25
Amlodipine Besylate	Amlodipine Besylate	200	23
Metoprolol Succinate	Metoprolol Succinate	195	22
Losartan Potassium	Losartan Potassium	182	17
Rivastigmine	Rivastigmine	182	18
Hydrochlorothiazide	Hydrochlorothiazide	175	23
Tamsulosin Hcl	Tamsulosin Hcl	169	16
Carvedilol	Carvedilol	158	17
Eliquis	Apixaban	155	19
Pantoprazole Sodium	Pantoprazole Sodium	154	17
Sertraline Hcl	Sertraline Hcl	154	15
Risperidone	Risperidone	148	15
Lidocaine	Lidocaine	143	36
Citalopram Hbr	Citalopram Hydrobromide	138	16
Methenamine Hippurate	Methenamine Hippurate	132	16
Quetiapine Fumarate	Quetiapine Fumarate	131	14
Mirtazapine	Mirtazapine	128	15
Duloxetine Hcl	Duloxetine Hcl	127	12
Diclofenac Sodium	Diclofenac Sodium	120	40
Ondansetron Odt	Ondansetron	115	50
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	111	16
Potassium Chloride	Potassium Chloride	93	12
Latanoprost	Latanoprost	89	12
Torsemide	Torsemide	87	suppressed
Jardiance	Empagliflozin	83	suppressed
Risperidone Odt	Risperidone	78	12
Lamotrigine	Lamotrigine	77	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	75	suppressed
Buspirone Hcl	Buspirone Hcl	72	suppressed
Klor-Con 10	Potassium Chloride	72	suppressed
Divalproex Sodium	Divalproex Sodium	70	suppressed
Tiotropium Bromide	Tiotropium Bromide	69	suppressed
Levetiracetam	Levetiracetam	65	suppressed
Olanzapine	Olanzapine	65	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	61	19
Cephalexin	Cephalexin	61	30
Clozapine	Clozapine	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	13
Clonazepam	Clonazepam	55	suppressed
Xarelto	Rivaroxaban	55	suppressed
Morphine Sulfate	Morphine Sulfate	52	21
Lithium Carbonate	Lithium Carbonate	51	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	49	11
Famotidine	Famotidine	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Divalproex Sodium Er	Divalproex Sodium	48	suppressed
Simvastatin	Simvastatin	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	suppressed
Propranolol Hcl	Propranolol Hcl	46	suppressed
Clotrimazole	Clotrimazole	45	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	44	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Bupropion Xl	Bupropion Hcl	43	suppressed
Memantine Hcl Er	Memantine Hcl	43	suppressed
Nyamyc	Nystatin	43	13
Pravastatin Sodium	Pravastatin Sodium	43	suppressed
Pregabalin	Pregabalin	43	suppressed
Aripiprazole	Aripiprazole	42	suppressed
Baclofen	Baclofen	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Metformin Hcl	Metformin Hcl	39	suppressed
Spironolactone	Spironolactone	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	16
Lorazepam	Lorazepam	33	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Finasteride	Finasteride	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Oxycontin	Oxycodone Hcl	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Olanzapine Odt	Olanzapine	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Lorazepam Intensol	Lorazepam	28	21
Trulicity	Dulaglutide	28	suppressed
Armour Thyroid	Thyroid,pork	27	suppressed
Haloperidol	Haloperidol	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Paliperidone Er	Paliperidone	27	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Atenolol	Atenolol	26	suppressed
Bupropion Hcl	Bupropion Hcl	26	suppressed
Diazepam	Diazepam	26	suppressed
Topamax	Topiramate	26	suppressed
Vimpat	Lacosamide	26	suppressed
Cholestyramine	Cholestyramine (With Sugar)	25	suppressed
Donepezil Hcl Odt	Donepezil Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Phenazopyridine Hcl	Phenazopyridine Hcl	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Rivastigmine	Rivastigmine Tartrate	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Perphenazine	Perphenazine	23	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	23	suppressed
Renacidin	Citric Ac/Gluconolact/Mag Carb	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Haloperidol Lactate	Haloperidol Lactate	21	20
Linzess	Linaclotide	21	suppressed
Atropine Sulfate	Atropine Sulfate	20	20
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Estradiol	Estradiol	19	suppressed
Flecainide Acetate	Flecainide Acetate	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Anastrozole	Anastrozole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Nitroglycerin	Nitroglycerin	16	12
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Glipizide	Glipizide	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Prednisone	Prednisone	14	suppressed
Primidone	Primidone	14	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	13	suppressed
Abilify Maintena	Aripiprazole	12	suppressed
Acyclovir	Acyclovir	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Entacapone	Entacapone	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Xtandi	Enzalutamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error